| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/26/2013 | US8404855 Substituted enaminocarbonyl compounds |
| 03/26/2013 | US8404854 Barium salt of benzimidazole derivative |
| 03/26/2013 | US8404852 Gyrase inhibitors and uses thereof |
| 03/26/2013 | US8404851 1,3,5-trisubstituted triazole derivative |
| 03/26/2013 | US8404850 Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors |
| 03/26/2013 | US8404848 Derivatives of imidazo[1,2-a]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics |
| 03/26/2013 | US8404847 Method for producing diamine derivative |
| 03/26/2013 | US8404845 2,3-substituted azaindole derivatives for treating viral infections |
| 03/26/2013 | US8404839 Crystalline 4-(3-chloro-2-fluoroanilino)-7 methoxy-6-{[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy} quinazoline difumarate Form A |
| 03/26/2013 | US8404833 Synthetic heparin disaccharides |
| 03/26/2013 | US8404805 Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 03/26/2013 | US8404793 Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 03/26/2013 | US8404752 Method of treating traumatic brain injury |
| 03/26/2013 | US8404751 Subunguicide, and method for treating onychomycosis |
| 03/26/2013 | US8404750 Methods for administration and formulations for the treatment of regional adipose tissue |
| 03/26/2013 | US8404749 Method of inhibiting inflammatory pain |
| 03/26/2013 | US8404748 Storage-stable formulation of paracetamol in aqueous solution |
| 03/26/2013 | US8404747 Compositions and methods for modulating interaction between polypeptides |
| 03/26/2013 | US8404746 Anti-diabetes composition containing chicoric acid and/or one of the metabolites thereof |
| 03/26/2013 | US8404745 Transdermal delivery of medicinal cetylated fatty esters using phonophoresis or iontophoresis |
| 03/26/2013 | US8404744 Methods of treatment and pharmaceutical composition |
| 03/26/2013 | US8404743 Zinc oxide complexes |
| 03/26/2013 | US8404742 Diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them |
| 03/26/2013 | US8404741 Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase |
| 03/26/2013 | US8404740 Spirocyclic cyclohexane compounds |
| 03/26/2013 | US8404738 4-amino-N-hydroxy-benzamides for the treatment of cancer |
| 03/26/2013 | US8404737 Substituted isoindoline-1,3-dione derivatives |
| 03/26/2013 | US8404736 Heterocyclic amide derivatives as EP4 receptor antagonists |
| 03/26/2013 | US8404735 Parasiticidal formulation |
| 03/26/2013 | US8404733 Laser enhanced amino acid blend and use of same to regenerate active myocardial tissue |
| 03/26/2013 | US8404732 Methods of treating ulcerative colitis |
| 03/26/2013 | US8404731 Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors |
| 03/26/2013 | US8404730 3-substituted propanamine compounds |
| 03/26/2013 | US8404729 Heterocyclic tetracyclic tetrahydrofuran derivatives |
| 03/26/2013 | US8404728 Small-molecule botulinum toxin inhibitors |
| 03/26/2013 | US8404727 Pharmaceutical composition that includes a dipeptidyl peptidase-IV inhibitor |
| 03/26/2013 | US8404726 Activating agent for peroxisome proliferator activated receptor δ |
| 03/26/2013 | US8404725 Phenylamino isonicotinamide compounds |
| 03/26/2013 | US8404724 Administering compound such as N-(5-chloro-pyridin-2-yl)-2-(4-cyano-benzoyl-amino)-5-methoxy-benzamide Hydrochloride for inhibiting coagulation |
| 03/26/2013 | US8404723 3-cyano 5-thiazaheteroaryl-dihydropyridine and the use thereof for the treatment of cardiovascular diseases |
| 03/26/2013 | US8404722 Oxazole compounds compositions and methods of use |
| 03/26/2013 | US8404720 Aryl sulfonamide amine compounds and their use as 5-HT6 ligands |
| 03/26/2013 | US8404719 Substituted piperidinylcarbonylbenzenesulfonamides as calcium channel blockers |
| 03/26/2013 | US8404718 Combinations of pyrazole kinase inhibitors |
| 03/26/2013 | US8404717 Methods of treating myelodysplastic syndromes using lenalidomide |
| 03/26/2013 | US8404716 Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine |
| 03/26/2013 | US8404715 Methods and compositions using racemic, (R)-, and (S)-fexofenadine in combination with leukotriene inhibitors |
| 03/26/2013 | US8404714 Combinations to improve animal health and performance |
| 03/26/2013 | US8404713 Quinolinone derivatives as PARP inhibitors |
| 03/26/2013 | US8404712 Quinuclidine carbonate salts and medicinal composition thereof |
| 03/26/2013 | US8404711 5-HT4 receptor agonist compounds for treatment of cognitive disorders |
| 03/26/2013 | US8404710 Phosphodiesterase 10A inhibitor |
| 03/26/2013 | US8404709 Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof |
| 03/26/2013 | US8404708 Dual NK1/NK3 receptor antagonists |
| 03/26/2013 | US8404707 Imidazo [1, 2-a] pyrrolo [3, 2-c] pyridine compounds useful as pestivirus inhibitors |
| 03/26/2013 | US8404706 Opioid and opioid-like compounds and uses thereof |
| 03/26/2013 | US8404705 Naphthalene amidine imides |
| 03/26/2013 | US8404704 Use of polymorphic forms of rifaximin for medical preparations |
| 03/26/2013 | US8404703 Medicinal compositions containing aspirin |
| 03/26/2013 | US8404702 Pharmaceutical formulations:salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same |
| 03/26/2013 | US8404701 Use and composition for treating dementia |
| 03/26/2013 | US8404700 Compounds modulating c-fms and/or c-kit activity and uses therefor |
| 03/26/2013 | US8404698 Quinazoline derivatives and therapeutic use thereof |
| 03/26/2013 | US8404697 Quinazoline derivatives for the treatment of cancer diseases |
| 03/26/2013 | US8404696 Quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same |
| 03/26/2013 | US8404695 Pyrimidinyl pyridone inhibitors of JNK |
| 03/26/2013 | US8404694 Aurora kinase modulators and method of use |
| 03/26/2013 | US8404693 Substituted piperidine compounds and methods of their use |
| 03/26/2013 | US8404692 Pyrimidin-4-yl-3, 4-dihydro-2H-pyrrolo [1,2A] pyrazin-1-one compounds |
| 03/26/2013 | US8404691 Imidazothiazole derivatives having proline ring structure |
| 03/26/2013 | US8404690 Piperazine-2-carboxamide derivatives |
| 03/26/2013 | US8404689 Heterocyclic amide compounds useful as kinase inhibitors |
| 03/26/2013 | US8404688 Nitrone compounds, process of preparation thereof, and use thereof in medicament manufacture |
| 03/26/2013 | US8404687 Disubstituted phthalazine hedgehog pathway antagonists |
| 03/26/2013 | US8404686 Method of treatment or prophylaxis |
| 03/26/2013 | US8404685 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors |
| 03/26/2013 | US8404684 Inhibitors of phosphatidylinositol 3-kinase |
| 03/26/2013 | US8404683 Inhibitors of the interaction between MDM2 and P53 |
| 03/26/2013 | US8404682 Di-substituted amides for enhancing glutamatergic synaptic responses |
| 03/26/2013 | US8404681 Xanthones, thioxanthones and acridinones as DNA-PK inhibitors |
| 03/26/2013 | US8404680 N-[3-(5-amino-3,3a,7,7a-tetrahydro-1H-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as BACE1 and/or BACE2 inhibitors |
| 03/26/2013 | US8404679 Pyrrolidine derivatives as NK2 receptor antagonists |
| 03/26/2013 | US8404678 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use |
| 03/26/2013 | US8404677 Kinase inhibitors |
| 03/26/2013 | US8404676 Oxadiazole diaryl compounds |
| 03/26/2013 | US8404675 Benzazepine derivatives and methods of prophylaxis or treatment of 5HT2C receptor associated diseases |
| 03/26/2013 | US8404674 Substituted 9H-purin-2-YL compounds, compositions thereof and uses thereof |
| 03/26/2013 | US8404673 Carbocyclic GlyT1 receptor antagonists |
| 03/26/2013 | US8404672 Substituted heterocyclic compounds |
| 03/26/2013 | US8404671 Heterosubstituted N-thiolated beta-lactam compounds and methods of use |
| 03/26/2013 | US8404670 Histamine H3 inverse agonists and antagonists and methods of use thereof |
| 03/26/2013 | US8404669 Kinase modulating compounds and uses thereof for treatment of cancer |
| 03/26/2013 | US8404668 Method of treating gaucher disease |
| 03/26/2013 | US8404667 2-methylene-19-nor-20(S)-1 alpha -hydroxy-bishomopregnacalciferol; 13-cis-retinoic acid activator; acne, psoriasis, ichthyosis, photoaging, photodamaged skin, skin cancer |
| 03/26/2013 | US8404666 2-substituted-1α,25-dihydroxy-19,26,27-trinor vitamin D analogs and uses thereof |
| 03/26/2013 | US8404665 In vivo use of glutathione S-transferase activated nitric oxide donors |
| 03/26/2013 | US8404664 Phosphonated Rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| 03/26/2013 | US8404663 Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators |
| 03/26/2013 | US8404662 Cyclodextrin-based polymers for therapeutics delivery |
| 03/26/2013 | US8404661 Wound-healing pharmaceutical compositions in the form of a cream based on amino acids and sodium hyaluronate |